Medicure (OTCMKTS:MCUJF) Shares Pass Above 50 Day Moving Average – Time to Sell?

Medicure Inc. (OTCMKTS:MCUJF)’s stock price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.83 and traded as high as $0.8327. Medicure shares last traded at $0.8327, with a volume of 2,081 shares changing hands.

Medicure Stock Performance

The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 1.04. The firm’s 50 day moving average is $0.83 and its 200-day moving average is $0.84. The firm has a market cap of $8.69 million, a price-to-earnings ratio of -1.77 and a beta of 0.98.

Medicure (OTCMKTS:MCUJF) last released its quarterly earnings data on Thursday, May 21st. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.01. Medicure had a negative net margin of 21.65% and a negative return on equity of 44.34%. The business had revenue of $5.79 million during the quarter, compared to analyst estimates of $3.63 million.

Medicure Company Profile

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.